Follow Us:
Cilnidipine Exporter From India

Cilnidipine

Cilnidipine is a dihydropyridine calcium channel blocker used primarily to treat hypertension (high blood pressure). It blocks L-type and N-type calcium channels, relaxing blood vessels, reducing vascular resistance and helping lower blood pressure. Cilnidipine is available as oral tablets and may be prescribed alone or in combination with other antihypertensive medicines. Common side effects include headache, dizziness, facial flushing, low blood pressure and swelling of the ankles or feet. Less common adverse effects may include palpitations, gastrointestinal discomfort and gum enlargement. It should be used under medical supervision, with regular blood-pressure monitoring and caution in patients with certain heart conditions or severe liver impairment.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Cilnidipine

Cilnidipine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Cilnidipine

Availability of Cilnidipine

Delivery of Cilnidipine

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Cilnidipine.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Cilnidipine.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cilnidipine, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Cilnidipine Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Cilnidipine

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Cilnidipine Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cilnidipine, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Cilnidipine

The export of Cilnidipine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Cilnidipine Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Cilnidipine specifications, certificates of analysis, and other supporting documents required for Cilnidipine export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Cilnidipine export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Cilnidipine regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Cilnidipine documentation, labelling, Cilnidipine manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Cilnidipine Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Cilnidipine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.